BlackRock, Inc. 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Lifecore Biomedical, Inc. LFCR |
BlackRock Inc. BLK |
532,043 1.800% |
-1,316,110 (-71.21%) |
Filing |
| 2023-02-01 4:54 pm Sale |
2022-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
BlackRock Inc. BLK |
1,848,153 6.200% |
-98,305 (-5.05%) |
Filing |
| 2022-02-01 5:08 pm Sale |
2021-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
BlackRock Inc. BLK |
1,946,458 6.600% |
-144,572 (-6.91%) |
Filing |
| 2021-01-29 5:23 pm Purchase |
2020-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
BlackRock Inc. BLK |
2,091,030 7.200% |
79,319 (+3.94%) |
Filing |